Atlas Trials

Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma

Clinical trial NCT01481870 · UNKNOWN

Trial details

NCT number
NCT01481870
Sponsor
Yamagata University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2010-01-01
Primary completion
2013-07-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.